Today: 28 January 2026
Subscribe
Browse Category

Tech Comparisons News 15 July 2025 - 31 July 2025

The Future Is Here: Top Gun Sights of 2025-2026 (Red Dots, Holographic, Thermal & More Compared)

The Future Is Here: Top Gun Sights of 2025-2026 (Red Dots, Holographic, Thermal & More Compared)

In 2025, enclosed-emitter micro red dots dominated the market, led by Aimpoint’s COA ultra-compact duty sight with an A-Cut mounting interface that locks directly into Glock slides. Trijicon released the Ruggedized Closed Reflex (RCR) for the RMR footprint, featuring a 7075-T6 Owl Ear housing, a top-loading battery, and waterproofing to 20 meters. C&H Precision introduced the EDC Enclosed micro red…
31 July 2025
Galaxy S25 Ultra vs iPhone 16 Pro Max vs Pixel 9 Pro vs OnePlus 13 – The Ultimate 2025 Flagship Showdown

Galaxy S25 Ultra vs iPhone 16 Pro Max vs Pixel 9 Pro vs OnePlus 13 – The Ultimate 2025 Flagship Showdown

The Galaxy S25 Ultra uses Qualcomm’s Snapdragon 8 Elite for Galaxy on a 3nm process with custom Oryon CPU cores, delivering about 9,829 Geekbench 6 multi-core points, ahead of the iPhone 16 Pro Max’s ~8,391. The S25 Ultra features a 6.9‑inch 1440×3120 Dynamic AMOLED 2X panel with up to 2600 nits peak brightness, Gorilla Glass Armor 2, and a flat-screen…
15 July 2025
·
Apple Watch Series 10 vs Series 9, Galaxy Watch, Pixel & More – The Ultimate 2025 Smartwatch Showdown

Apple Watch Series 10 vs Series 9, Galaxy Watch, Pixel & More – The Ultimate 2025 Smartwatch Showdown

Apple Watch Series 10 adds a 42mm and 46mm edge-to-edge LTPO OLED display with thinner bezels, and the 46mm panel has more display area than the 49mm Apple Watch Ultra. It introduces a titanium case option in slate, natural, or gold finishes, with titanium models lighter and more scratch-resistant than stainless steel. Series 10 inherits a water-depth sensor and a…
15 July 2025
··
1 2 3 4

Stock Market Today

  • Insulet (PODD) Stock Valuation Reflects Share Price Weakness and Growth Expectations
    January 28, 2026, 12:31 AM EST. Insulet's stock has declined over recent periods, with a 7% drop in the past week and over 6% year to date. The company, known for insulin delivery technology, faces investor scrutiny over long-term adoption and competitive pressures in diabetes care. A Discounted Cash Flow (DCF) analysis values Insulet at $324.22 per share, suggesting it is about 18.3% undervalued compared to its last closing price of $264.91. However, its price-to-earnings (P/E) ratio stands at 75.69 times, markedly higher than the industry average of 31.67 and peer average of 46.07, indicating high growth expectations but also increased risk perception. Overall, Insulet scores a low 2 out of 6 on valuation checks, reflecting mixed signals for investors assessing its market position and future prospects.
Go toTop